Neuromodulation Market Demonstrates Long-Term Growth Potential At 11.1% CAGR
The Business Research Company's Neuromodulation Market Demonstrates Long-Term Growth Potential At 11.1% CAGR Expected
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
The Business Research Company’s Neuromodulation Market Demonstrates Long-Term Growth Potential At 11.1% CAGR
LONDON, GREATER LONDON, UNITED KINGDOM, August 19, 2026 /EINPresswire.com/ — “The neuromodulation market has been experiencing notable expansion recently, driven by advancements in medical technology and increasing demand for innovative pain and neurological disorder treatments. As the industry evolves, it is set to witness even stronger growth fueled by emerging technologies and expanding applications. Here’s a detailed look at the current market size, growth factors, regional outlook, and key influences shaping this sector.
Neuromodulation Market Size and Growth Projections Through 2026
The neuromodulation market has expanded swiftly in recent years and is projected to continue this upward trajectory. From $7.62 billion in 2025, it is expected to grow to $8.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. This past growth is largely due to the rising prevalence of chronic pain conditions, an increase in neurological disorders, a broader acceptance of minimally invasive treatment options, the growth of specialized pain management centers, and the availability of advanced implantable neuromodulation devices.
Download a free sample of the neuromodulation market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Looking ahead, the neuromodulation market is forecasted to maintain rapid growth, reaching $12.88 billion by 2030 with a CAGR of 11.1%. This anticipated expansion is driven by the growing use of AI-assisted neuromodulation systems, a rising demand for home-based therapies, an increasing range of indications in psychiatric and neurological disorders, a focus on patient-specific stimulation protocols, as well as ongoing technological improvements in biomaterials and device miniaturization. Key trends expected to shape the market include wider adoption of implantable devices, increased use of non-invasive treatments, integration of smart and programmable stimulators, diversification of neuromodulation applications beyond pain management, and a stronger emphasis on personalized neurotherapy approaches.
Understanding Neuromodulation and Its Purpose
Neuromodulation involves altering nerve activity by applying electrical or pharmacological agents directly to targeted areas. This method is typically reversible and primarily used to alleviate pain by modulating nerve signals at specific locations. It offers a minimally invasive solution to manage chronic pain and other neurological conditions, improving patients’ quality of life through targeted therapy.
View the full neuromodulation market report:
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Healthcare Spending as a Key Growth Driver for the Neuromodulation Market
An important factor fueling the neuromodulation market’s expansion is the continuous rise in healthcare expenditures worldwide. Healthcare spending includes all funds allocated toward medical services, insurance, research, and public health initiatives. Increased investment in healthcare supports the development and adoption of novel therapies and diagnostic techniques for neurological disorders. Moreover, it provides greater resources for research aimed at enhancing neuromodulation technologies, improving their safety, effectiveness, and precision. For example, data from May 2024 by the UK’s Office for National Statistics show that total healthcare expenditure increased by 5.6% in nominal terms during 2023, marking a 0.9% growth over 2022. This upward trend in healthcare budgets is a significant contributor to the neuromodulation market’s positive outlook.
North America’s Leadership Role in the Neuromodulation Market by 2026
In 2025, North America held the largest share of the neuromodulation market, affirming its position as a dominant region. The market report also includes analysis of key geographic areas such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. While North America currently leads, other regions are expected to contribute significantly to market growth in the coming years.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery

